Gabriela Plesa

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Carl H. June · 2 shared papers, 2020–2025 · strength 0.26
   • Paper Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. DOI 10.1016/j.xcrm.2025.102301↗
   • Paper Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancr… DOI 10.1016/j.ymthe.2020.07.017↗
2. Mark H. O’Hara · 2 shared papers, 2020–2025 · strength 0.26
   • Paper Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. DOI 10.1016/j.xcrm.2025.102301↗
   • Paper Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancr… DOI 10.1016/j.ymthe.2020.07.017↗
3. Andrew H. Ko · 1 shared paper, 1 shared trial, 2015–2020 · strength 0.25
   • Trial Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer NCT02465983↗
   • Paper Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancr… DOI 10.1016/j.ymthe.2020.07.017↗
4. Andrew J. Rech · 1 shared paper, 2025 · strength 0.17
   • Paper Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. DOI 10.1016/j.xcrm.2025.102301↗
5. Andrew Haas · 1 shared paper, 2025 · strength 0.17
   • Paper Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. DOI 10.1016/j.xcrm.2025.102301↗
6. Joseph A. Fraietta · 1 shared paper, 2025 · strength 0.17
   • Paper Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. DOI 10.1016/j.xcrm.2025.102301↗
7. Janos Laszlo Tanyi · 1 shared paper, 2025 · strength 0.17
   • Paper Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. DOI 10.1016/j.xcrm.2025.102301↗
8. Maria Angela Aznar · 1 shared paper, 2025 · strength 0.17
   • Paper Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. DOI 10.1016/j.xcrm.2025.102301↗
9. Hua Huang · 1 shared paper, 2025 · strength 0.17
   • Paper Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. DOI 10.1016/j.xcrm.2025.102301↗
10. Don L. Siegel · 1 shared paper, 2025 · strength 0.17
    • Paper Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. DOI 10.1016/j.xcrm.2025.102301↗
11. Lawrence H. Fong · 1 shared paper, 2020 · strength 0.09
    • Paper Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancr… DOI 10.1016/j.ymthe.2020.07.017↗
12. Alan Paul Venook · 1 shared paper, 2020 · strength 0.09
    • Paper Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancr… DOI 10.1016/j.ymthe.2020.07.017↗
13. Margaret A. Tempero · 1 shared paper, 2020 · strength 0.09
    • Paper Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancr… DOI 10.1016/j.ymthe.2020.07.017↗
14. Gregory Lawrence Beatty · 1 shared paper, 2020 · strength 0.09
    • Paper Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancr… DOI 10.1016/j.ymthe.2020.07.017↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.